Randomized Controlled Trial
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jun 21, 2015; 21(23): 7305-7312
Published online Jun 21, 2015. doi: 10.3748/wjg.v21.i23.7305
Table 1 Patient demographic and baseline characteristics n (%)
rSK-ArSK-BHydrocortisoneTotal
n170170170510
GenderMale/female (%male)90/80 (52.9)95/75 (55.9)92/78 (54.1)277/233 (54.3)
EthnicityWhite76 (44.7)98 (57.6)80 (47.1)254 (49.8)
Black18 (10.6)18 (10.6)20 (11.8)56 (11.0)
Mestizo76 (44.7)54 (31.8)70 (41.2)200 (39.2)
AgeMedian ± QR (Min; Max)46 ± 19 (19; 75)46 ± 14 (19; 75)46 ± 18 (18; 74)46 ± 17 (18; 75)
Days from start of symptoms to treatment onsetMedian ± QR (Min; Max)3 ± 2 (0; 22)2 ± 1 (0; 27)2 ± 1 (0; 15)3 ± 1 (0; 27)
Classification of the hemorrhoidsExternal103 (60.6)112 (65.9)112 (65.9)327 (64.1)
Internal56 (32.9)51 (30.0)48 (28.2)155 (30.4)
Mixed11 (6.5)7 (4.1)10 (5.9)28 (5.5)
Grade of prolapse, (I or II):(III or IV)54:1337:2143:15134:49
Presence of thrombosis122 (71.8)129 (75.9)133 (78.2)384 (75.3)
Debut of disease130 (76.5)122 (71.8)123 (72.4)375 (73.5)
Previous thrombectomy12 (7.1)12 (7.1)11 (6.5)35 (6.9)

  • Citation: Hernández-Bernal F, Castellanos-Sierra G, Valenzuela-Silva CM, Catasús-Álvarez KM, Martínez-Serrano O, Lazo-Diago OC, Bermúdez-Badell CH, Causa-García JR, Domínguez-Suárez JE, Investigators PALST4(OHWRSAGO. Recombinant streptokinase vs hydrocortisone suppositories in acute hemorrhoids: A randomized controlled trial. World J Gastroenterol 2015; 21(23): 7305-7312
  • URL: https://www.wjgnet.com/1007-9327/full/v21/i23/7305.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v21.i23.7305